Ask Me Anything about AmyloSENS - Dr. Sudhir Paul and Michael Rae
Рет қаралды 338
Күн бұрынMichael Rae (Science Writer for SENS Research Foundation) asks Dr. Sudhir Paul (CSO, Covalent Biosciences) about his AmyloSENS area of research. Dr. Paul is an extramural researcher for SENS Research Foundation. This video is part of our End of Year Campaign 2022 | Week 7: AmyloSENS | www.sens.org/eoy2022
@SirTenenbaum Жыл бұрын
Their research on catalytic antibodies (as opposed to binding antibodies) is so cool! Dr. Paul's specific assessment at 24:19 of aduhelm and lecanemab and how catabodies may be a considerably superior approach was extremely informative.
@FroggyTWrite Жыл бұрын
it's nice to see you folks posting more often
@SENSRF Жыл бұрын
Thank you for your kind words! We'll definitely be looking into posting more interviews with our thought leaders, scientists, and researchers so more people can learn about the exciting developments in longevity science! Stay tuned!
@tintin_999 Жыл бұрын
Liz Parish and BioViva should start offering Amyloid Beta Catabody gene therapy treatment for Alzheimers down in Colombia.
SENS Research Foundation
Рет қаралды 614
SENS Research Foundation
Рет қаралды 550
The Doctor That Got Banned For Speaking Out:“We've Been Lied To About Medication!” Dr Aseem Malhotra
The Diary Of A CEO
Рет қаралды 69 М.
Joseph Raczynski
Рет қаралды 527 М.
Stanford Graduate School of Business
Рет қаралды 39 МЛН
Immersed
Рет қаралды 5 МЛН